ClassID:

20251

A61K31/215 - page 4 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids

Recent Application in this class:
#901
20070259890
2007-11-08

Compounds and compositions as PPAR modulators

#902
20070254950
2007-11-01

Oculoselective Drugs and Prodrugs

#903
20070248658
2007-10-25

Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers

#904
20070243238
2007-10-18

Treating mouth sores with patches adhered to teeth

#905
20070243230
2007-10-18

Nasolacrimal drainage system implants for drug therapy

#906
20070238784
2007-10-11

Anthracenedione compounds

#907
20070232656
2007-10-04

Pharmaceutical Composition And Method For Treating Neurodegenerative Disorders

#908
20070203241
2007-08-30

Antiviral treatments

#909
20070190136
2007-08-16

Process for producing fenofibrate tablets

#910
20070185055
2007-08-09

Method for treating cachexia with retinoid ligands

#911
20070184131
2007-08-09

Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof

#912
20070184103
2007-08-09

Process for producing fenofibrate tablets

#913
20070184097
2007-08-09

Adhesive preparations

#914
20070161704
2007-07-12

Pharmaceutical composition useful for treating chronic myeloid leukemia

#915
20070149616
2007-06-28

C3-Convertase Inhibitors for the Prevention and Treatment of Age-Related Macular Degeneration in Patients With At Risk Variants Of Complement Factor H

#916
20070142539
2007-06-21

Octahydronaphthalene derivative and medicine

#917
20070129435
2007-06-07

Pharmaceutical Composition For Treating Stress Incontinence And/Or Mixed Incontinence

#918
20070123491
2007-05-31

Podophyllotoxin derivatives as igf-1r inhibitors

#919
20070100001
2007-05-03

Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof

#920
20070099868
2007-05-03

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#921
20070087063
2007-04-19

Medical composition for balancing bodily processes

#922
20070060605
2007-03-15

Compositions and methods for inhibiting platelet activation and thrombosis

#923
20070059378
2007-03-15

Medical composition for balancing bodily processes

#924
20070049585
2007-03-01

BENZAMIDE AND BENZOATE ANTI-HIV COMPOUNDS

#925
20070042056
2007-02-22

Anti-stress agent

#926
20070036869
2007-02-15

Methods for prophylactic and therapeutic nutritional supplementation

#927
20070031487
2007-02-08

Nutritional supplement for women

#928
20070015827
2007-01-18

Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (RBP), and/or serum retinol-RBP modulation

#929
20070009451
2007-01-11

Cosmetic and/or pharmaceutical compositions for the cure and prevention of irritation, inflammation and cutaneous erythema

#930
20070004800
2007-01-04

Immunoregulatory compounds and derivatives and methods of treating diseases therewith

#931
20060276372
2006-12-07

Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders

#932
20060270735
2006-11-30

Stable prostaglandin-containing compositions

#933
20060264455
2006-11-23

Use of huperzine for disorders

#934
20060264454
2006-11-23

Use of huperzine for neuropathic pain

#935
20060252832
2006-11-09

Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators

#936
20060240131
2006-10-26

Process for effecting the relaxation of muscles of a human by means of fragrance

#937
20060235078
2006-10-19

Insulin secretion potentiator

#938
20060229470
2006-10-12

Calcium receptor-active molecules

#939
20060229364
2006-10-12

Antiviral compositions and methods of use

#940
20060223887
2006-10-05

Method for treating acute pancreatitis

#941
20060211766
2006-09-21

Gelled immunomodulating topical compositions and a method of treating warts and other human papilloma virus skin infections

#942
20060194878
2006-08-31

Methods of cardioprotection using dichloroacetate in combination with an inotrope

#943
20060188572
2006-08-24

Controlled release of S-methoprene and other active ingredients with activated carbon

#944
20060173078
2006-08-03

Method of treatment or prophylaxis of symptoms of herpes viral infection

#945
20060167098
2006-07-27

Method for the treatment of diseases linked to an accumulation of triglycerides and cholesterol

#946
20060167088
2006-07-27

Methods and compositions for treating ophthalmic conditions with retinyl derivatives

#947
20060160890
2006-07-20

Triterpenoid derivatives

#948
20060148732
2006-07-06

Inhibition of NF-kappaB by triterpene compositions

#949
20060147397
2006-07-06

Composition for preparation for external use on skin and method of using the same

#950
20060134237
2006-06-22

Anti-microbial composition and methods of use thereof

#951
20060134161
2006-06-22

Water-swellable polymers

#952
20060128742
2006-06-15

Cell migration inhibiting compositions and methods and compositions for treating cancer

#953
20060122275
2006-06-08

Agentfor reducing side effects of diclofenac

#954
20060122270
2006-06-08

Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism

#955
20060099200
2006-05-11

Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger

#956
20060094783
2006-05-04

Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof

#957
20060094063
2006-05-04

Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation

#958
20060067991
2006-03-30

Non-absorbent articles for inhibiting the production of exoproteins

#959
20060063835
2006-03-23

Composition based on triethyl citrate for the treatment of bacterial infections of the skin

#960
20060058288
2006-03-16

Severe sepsis preventive therapeutic agent

#961
20060035873
2006-02-16

Methods for inducing apolipoprotein e secretion

#962
20060019955
2006-01-26

Oculoselective drugs and prodrugs

#963
20060004105
2006-01-05

Pharmaceutical composition for treating stress incontinence and/or mixed incontinence

#964
20050288236
2005-12-29

Substituted fullerene formulations and their use in ameliorating oxidative stress diseases or inhibiting cell death

#965
20050282892
2005-12-22

Pharmaceutical composition useful for treating chronic myeloid leukemia

#966
20050282785
2005-12-22

Topical administration of amifostine and related compounds

#967
20050272813
2005-12-08

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#968
20050272701
2005-12-08

Pharmaceutical composition

#969
20050266047
2005-12-01

Ocular implants with anchors and methods thereof

#970
20050265930
2005-12-01

Physiological cooling compositions

#971
20050261369
2005-11-24

Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor

#972
20050261328
2005-11-24

Pharmaceutical composition comprising beta-3-adrenoceptor-agonists and antimuscarinic agents

#973
20050256189
2005-11-17

Method of treating dry eye disorders and uveitis

#974
20050228051
2005-10-13

Immunoregulatory compounds and derivatives and methods of treating diseases therewith

#975
20050221272
2005-10-06

Methods of identifying agents that mediate polypeptide aggregation

#976
20050220905
2005-10-06

Formulations useful in the treatment of male and female impotence

#977
20050209325
2005-09-22

Method of treating inflammation with acanthoic acid derivatives

#978
20050192353
2005-09-01

Treating or preventing restless legs syndrome using prodrugs of GABA analogs

#979
20050171214
2005-08-04

Medicament for improving the failure of accommodation

#980
20050143464
2005-06-30

Insulin secretion potentiator

#981
20050137259
2005-06-23

Insulin secretion potentiator

#982
20050137166
2005-06-23

Use of cooling agents to relieve mild ocular irritation and enhance comfort

#983
20050129830
2005-06-16

Oil or fat composition

#984
20050123576
2005-06-09

Mupirocin compositions for topical use, an improved process of making same and methods of using same

#985
20050123575
2005-06-09

Spreadable compositions for topical use, an improved process of making same and methods of using same

#986
20050101607
2005-05-12

Pharmaceutical composition containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha reductase inhibitor

#987
20050096396
2005-05-05

Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning

#988
20050089585
2005-04-28

Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof

#989
20050089485
2005-04-28

Sulfacetamide formulations for treatment of rosacea

#990
20050085539
2005-04-21

Method of reducing toxicity of retinoids

#991
20050075402
2005-04-07

Guanidinomethyl cyclohexane carboxylic acid ester derivatives

#992
20050075396
2005-04-07

Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemia

#993
20050075367
2005-04-07

Ester compound and medicinal use thereof

#994
20050058730
2005-03-17

Compositions and methods for preventing or treating eyestrain

#995
20050054728
2005-03-10

Immunoregulatory compounds and derivatives and methods of treating diseases therewith

#996
20050054676
2005-03-10

Materials and methods for the treatment of depression

#997
20050043391
2005-02-24

Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome

#998
20050015039
2005-01-20

Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

#999
17380325
2022-03-08

Maslinic and oleanolic acids derivatives for treating SARS-CoV-2 infection

#1000
16793278
2022-10-11

Mecuna pruriens, L-DOPA and 5-HTP based dietary supplements, pharmaceutical formulations and uses thereof

#1001
16658099
2022-03-08

Omega-3 fatty acid nutriceutical compositions and methods

#1002
16201986
2020-03-10

Apparatus and formulation for treating mouth ulcers

#1003
15812671
2018-09-25

Solid oral formulations having an iron sugar overcoat

#1004
14739731
2016-08-09

3-O-acyl-ingenol analogues

#1005
14251632
2017-04-04

Omega-3 fatty acid nutriceutical composition and optimization method